These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 22728070)

  • 1. Reactive oxygen species are required for β2 adrenergic receptor-β-arrestin interactions and signaling to ERK1/2.
    Singh M; Moniri NH
    Biochem Pharmacol; 2012 Sep; 84(5):661-9. PubMed ID: 22728070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor.
    Shenoy SK; Drake MT; Nelson CD; Houtz DA; Xiao K; Madabushi S; Reiter E; Premont RT; Lichtarge O; Lefkowitz RJ
    J Biol Chem; 2006 Jan; 281(2):1261-73. PubMed ID: 16280323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-coupled receptor kinases (GRKs) orchestrate biased agonism at the β
    Choi M; Staus DP; Wingler LM; Ahn S; Pani B; Capel WD; Lefkowitz RJ
    Sci Signal; 2018 Aug; 11(544):. PubMed ID: 30131371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization.
    Ménard L; Ferguson SS; Zhang J; Lin FT; Lefkowitz RJ; Caron MG; Barak LS
    Mol Pharmacol; 1997 May; 51(5):800-8. PubMed ID: 9145918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
    Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
    Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
    Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
    Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gαs is dispensable for β-arrestin coupling but dictates GRK selectivity and is predominant for gene expression regulation by β2-adrenergic receptor.
    Burghi V; Paradis JS; Officer A; Adame-Garcia SR; Wu X; Matthees ESF; Barsi-Rhyne B; Ramms DJ; Clubb L; Acosta M; Tamayo P; Bouvier M; Inoue A; von Zastrow M; Hoffmann C; Gutkind JS
    J Biol Chem; 2023 Nov; 299(11):105293. PubMed ID: 37774973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine redox state regulates human β2-adrenergic receptor binding and function.
    Rambacher KM; Moniri NH
    Sci Rep; 2020 Feb; 10(1):2934. PubMed ID: 32076070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.
    Goodman OB; Krupnick JG; Santini F; Gurevich VV; Penn RB; Gagnon AW; Keen JH; Benovic JL
    Nature; 1996 Oct; 383(6599):447-50. PubMed ID: 8837779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin type 1A receptor regulates β-arrestin binding of the β
    Tóth AD; Gyombolai P; Szalai B; Várnai P; Turu G; Hunyady L
    Mol Cell Endocrinol; 2017 Feb; 442():113-124. PubMed ID: 27908837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arf6 negatively controls the rapid recycling of the β2 adrenergic receptor.
    Macia E; Partisani M; Paleotti O; Luton F; Franco M
    J Cell Sci; 2012 Sep; 125(Pt 17):4026-35. PubMed ID: 22611259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal regulation of β
    Pearce A; Sanders L; Brighton PJ; Rana S; Konje JC; Willets JM
    Cell Signal; 2017 Oct; 38():182-191. PubMed ID: 28733084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of arrestin recruitment by a G-protein-coupled receptor.
    Shukla AK; Westfield GH; Xiao K; Reis RI; Huang LY; Tripathi-Shukla P; Qian J; Li S; Blanc A; Oleskie AN; Dosey AM; Su M; Liang CR; Gu LL; Shan JM; Chen X; Hanna R; Choi M; Yao XJ; Klink BU; Kahsai AW; Sidhu SS; Koide S; Penczek PA; Kossiakoff AA; Woods VL; Kobilka BK; Skiniotis G; Lefkowitz RJ
    Nature; 2014 Aug; 512(7513):218-222. PubMed ID: 25043026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors.
    Azzi M; Charest PG; Angers S; Rousseau G; Kohout T; Bouvier M; Piñeyro G
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11406-11. PubMed ID: 13679574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer.
    Violin JD; Ren XR; Lefkowitz RJ
    J Biol Chem; 2006 Jul; 281(29):20577-88. PubMed ID: 16687412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling.
    Wisler JW; DeWire SM; Whalen EJ; Violin JD; Drake MT; Ahn S; Shenoy SK; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16657-62. PubMed ID: 17925438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation.
    Coffa S; Breitman M; Hanson SM; Callaway K; Kook S; Dalby KN; Gurevich VV
    PLoS One; 2011; 6(12):e28723. PubMed ID: 22174878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a β-arrestin-biased negative allosteric modulator for the β
    Ippolito M; De Pascali F; Hopfinger N; Komolov KE; Laurinavichyute D; Reddy PAN; Sakkal LA; Rajkowski KZ; Nayak AP; Lee J; Lee J; Cao G; Donover PS; Reichman M; An SS; Salvino JM; Penn RB; Armen RS; Scott CP; Benovic JL
    Proc Natl Acad Sci U S A; 2023 Aug; 120(31):e2302668120. PubMed ID: 37490535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma.
    Walker JK; DeFea KA
    Curr Opin Pharmacol; 2014 Jun; 16():142-7. PubMed ID: 24907413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of pepducins as Gs-biased allosteric agonists.
    Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL
    J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.